Pancreatic carcinoma metastatic: Which Medications Are Safest? (246 Drugs Compared)
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
246 medications are used for Pancreatic carcinoma metastatic, with 5,328 combined adverse event reports. The most reported drugs for Pancreatic carcinoma metastatic are PACLITAXEL and GEMCITABINE.
5,328
Total Reports
246
Drugs Used
All Medications for Pancreatic carcinoma metastatic Ranked by Safety Reports
| Drug | Brand | Reports | Deaths (all) | Hosp. (all) | Death Rate |
|---|---|---|---|---|---|
| PACLITAXEL | PACLITAXEL PACLITAXEL | 2,712 | 12,030 | 31,638 | 15.6% |
| GEMCITABINE | Gemcitabine | 1,586 | 5,142 | 12,268 | 16.4% |
| GEMCITABINE\GEMCITABINE | - | 1,171 | 2,206 | 3,666 | 21.6% |
| OXALIPLATIN | Oxaliplatin | 1,080 | 6,501 | 21,980 | 11.5% |
| FLUOROURACIL | FLUOROURACIL | 1,073 | 6,997 | 20,941 | 13.2% |
| IRINOTECAN | Irinotecan Hydrochloride | 977 | 4,530 | 10,384 | 16.2% |
| LEUCOVORIN | LEUCOVORIN CALCIUM | 637 | 3,932 | 10,039 | 15.7% |
| CAPECITABINE | Capecitabine | 285 | 8,892 | 17,529 | 14.0% |
| DURVALUMAB | IMFINZI | 184 | 5,088 | 5,968 | 29.7% |
| TREMELIMUMAB | IMJUDO | 142 | 594 | 1,510 | 24.9% |
| LEUCOVORIN\LEUCOVORIN | - | 122 | 549 | 1,588 | 14.4% |
| ERLOTINIB | Erlotinib | 112 | 6,791 | 3,693 | 30.2% |
| PEMBROLIZUMAB | KEYTRUDA | 108 | 15,543 | 35,472 | 18.6% |
| CISPLATIN | CISplatin | 105 | 8,387 | 17,469 | 17.7% |
| DEMCIZUMAB | - | 85 | 18 | 70 | 13.0% |
| NIVOLUMAB | OPDIVO | 81 | 23,086 | 36,530 | 26.3% |
| INVESTIGATIONAL PRODUCT | - | 79 | 740 | 4,035 | 13.8% |
| ATEZOLIZUMAB | Tecentriq Hybreza | 69 | 8,520 | 15,094 | 25.3% |
| TRASTUZUMAB | Trazimera | 62 | 5,564 | 13,839 | 12.0% |
| BEVACIZUMAB | JOBEVNE | 55 | 17,498 | 23,114 | 22.4% |